Latest / Stand In The Circle / Stand in the Circle 5.3: Dr. Anne Wagner - MDMA and Couples Therapy
Transcript
- speaker-0: am reaffirmed through it that bringing a loved one alongside you in the process is incredibly powerful. The way we actually set it up in the room, our particular therapy room, we use futons that are made up like beds. And we have people's heads close together and their feet kind of out in a V. speaker-1: Welcome to Stand in the Circle with me, Dr. Oslyn Watts. I'm a clinical psychologist, researcher, and founder of Acer Integration. This podcast is about how we get connected in a culture that pulls us apart. We talk about the hardest experiences of being human and the circles of care we have needed, couldn't find, and are searching for now, with stories from people who've lived it and researchers and practitioners. Healing in community is the older way. The work of our time is to rebuild our connectedness to ourselves, to each other, and to the living world. So welcome Dr. Anne Wagner, clinical psychologist, psychedelic researcher looking into couples therapy and MBMA, and also the founder and director of the Remedy Clinic and the Remedy Institute. Welcome Anne. speaker-0: thanks so much for having me, Ross. speaker-1: So I'd love you to talk a bit about your journey from being a clinical psychologist to being a psychedelic researcher in the particular area you've chosen and also founding this clinic in Canada. How did you get here? speaker-0: Yeah. So I think I've always been really interested in relationships. I think that's been a driving through line in all of my professional work, also my personal life. Like I love hearing about people's relationships and the relationships in my life are very important to me. And I'm always curious about what makes them work or what makes them not work and why they feel good or they don't feel good. And So when I went into grad school to become a psychologist, I was I knew I was really curious about couples therapy and I wanted to understand, okay, how do you work with two people who supposedly love each other and are in conflict together or maybe not or want to work through something difficult. So that was always present for me. And then I was also really interested in trauma. And that was something that I think From an early, relatively early age, I understood was actually a lot more common than we thought it was. And I had a grandfather who was a a veteran of World War II. He had been a bomber pilot. And he worked as a civil servant in Canada for a long time, supporting veterans' affairs. And so I knew that from a historical lens. And then so was curious about it as a as a student and as a burgeoning therapist and researcher. So I got involved in a trial that was run by my someone who became my postdoc mentor, Candace Monson, who was developing a couples therapy for PTSD. And I thought that that was so interesting. I was like, well, amazing, you can try to heal something that's really challenging and difficult together and also acknowledging the impact on both people. And so that was something That, I had witnessed in various ways is that when one person has a mental health condition, it isn't just that person who's impacted. It's it's everybody around them. It's their loved ones, it's their family, it's their community. And so that felt really powerful and important to me to be thinking about that and thinking about that in a more systemic way. and so I started to get involved in that. as a grad student and I was a therapist on that original trial of CBCT, which is the name of the therapy called cognitive behavioral conjoint therapy for PTSD. And then I entered my postdoc again with Candace, and we got approached by MAPS, so the Multidisciplinary Association for Psychedelic Studies, to potentially collaborate. And so that was early in the days of It's so funny to say early in the days now. to me, it does not feel that long ago, but it was, twelve, thirteen years ago at this point, to potentially consider what would it look like if we added MDMA sessions to CBCT? Could that amplify what it was that we were looking at? And at that point, I was totally naive to psychedelics. Like I'm I I knew about them, but I had never taken one at the point. I never I didn't know the research. But as soon as we started talking about that, I really dove into learning about it. And I was like, that sounds like it could be a really interesting and helpful tool. And at the time there was a study that was running for therapists where if you were gonna be working on an MDMA trial, you could enter this this trial and have your own MDMA therapy experience. And so I had an opportunity to participate in that trial. And so I both had a placebo session and an MDMA session. And so I had a firsthand experience of understanding what it was like to have that. And that that was my first experience with a a quote-unquote psychedelic. And I know that's people argue whether MDMA is a psychedelic or not. In my mind, it definitely is. So it's that experience really helped me help me personally, but also helped me understand. what it could offer in those moments. And I think that was the catalyst for this idea of combining these things together. And so our team developed this protocol where we d we put two MDMA sessions with a course of C B C speaker-1: See. speaker-0: and we piloted that and the results were really amazing. And it was a very small sample, of course. We were just trying to figure out a signal for it. But the impact it had was It really helped to loosen some of the knots that I was seeing in the relationships and within the trauma. And so in that trial in particular, we had a lot of folks who'd been together for a very long time and who had very long standing traumas. And you know, you end up with patterns in behavior and patterns in relationship that try to help it work, right? You you just try to get by. And a lot of the partners were doing a lot to make life okay for the person who had PTSD. And they're often, the the saying of like they're holding it all together and they're walking on eggshells at the same time. And that is a huge burden to put on everybody. And obviously the person with PTSD is suffering. Like they're in a really challenging emotional condition as well. And what was interesting is that some of those couples were Happy. they would rate themselves on a happiness scale as in the happy range. But in others, we're not happy. And it we, you know, we didn't include people based on if they were happy or not, but we were certainly curious to see what's going happen with that as you shift and shake up the system and see what's going on there. And we found that. the vast majority of folks had improvement in their PTSD symptoms and the vast majority of folks had improvement in their relationship satisfaction as well, both the person with PTSD and the partner. And so that to us was really important information. And I was particularly struck with how much the partners improved in terms of like their own mental health and their own experiences of feeling well in the relationship. So that was, you know, very eye-opening for me as a clinician, as a researcher, I became really fascinated by it. And at the time, so this would have been around twenty seventeen, that we were, you know, in the midst of this and starting to think about coming to the end of that study. And I was at the juncture in my career where I had to figure out what was next. I was my postdoc was I had about a year left in my postdoc and I thought I wanted to go into academia, but at the time Particularly here in Canada, the idea of doing psychedelic research in an academy was not really feasible at that point. We were having difficulties with our ethics boards even understanding this research, let alone the whole university supporting it or a hospital system. So this was before the wave of it starting to come into these different institutions. And at that point, I already had a funding commitment by philanthropy to fund another. pilot trial. And so I had that I knew I had that C funding for study. And then I thought about okay, what am I how am I gonna make this work? I like this is not enough to you know convince a university at the moment. So I decided to start Remedy and Remedy Institute. And that was that was one of the big reasons. But the other reason was What I was finding was that I had so many very talented colleagues as psychologists who felt like they had to make these very strict choices between do we become clinicians, do we become therapists, or do we become researchers? And there wasn't a lot of middle ground. And all of the we I know most of us were hoping for these positions where we would do both. You know, we all dreamt of these hospital-based government funded positions where you would do, you know, fifty percent clinical, fifty percent research, a little teaching, a little supervision, and that would be the dream. And that wasn't the case for anybody. Like no one no one ended up in that position. And I knew that there was also in the production of knowledge, when you only have it coming from sources that are in fully within the academy, you've only got certain voices and certain experiences that are forwarding them. So my hope was to create a model that could exist as a standalone where you could do research and you could be a clinician and it could generally be self-funded with some of these bigger infusions of philanthropic dollars or grant dollars that could run a larger study. So I developed the concept of the remedy ecosystem, which has remedy, which has a clinic. And so we're a full service psychotherapy clinic. Where people will come and receive therapy and treatment. and we're, you know, have a lot of expertise in psychedelic assisted therapies, prep and integration, as well as a lot of trauma work, a lot of mood disorders, anxiety, couples, you know, the whole spectrum. And the profit from that clinic is donated to Remedy Institute, which is the charity. So we actually run as a not-for-profit model and The charity is where we run our research and where we offer bursaries for no cost services for folks who can't afford therapy. And so in Remedy Institute is where we run our current MDMA trials. And that's been quite the journey to figure out how to stand up a non-pharma, non-university, non-hospital based research institute. but we've done it. We've we're on our second MDMA trial, which is amazing. We run one that was an individual trial using cognitive processing therapy, and now we're doing a large couples therapy study. And that to me is so exciting to get to take what we learned in the pilot and extend it into a bigger group of people. And right now we're comparing that combination of C B C T plus MDMA versus C B C T on its own. And then that group, after they're done, can opt in and get to MDMA sessions in general couples therapy. So that's the bit where my brain is working and and figuring that part out is how do we optimize that experience for folks where it could be trauma focused, it doesn't have to be. They can focus on whatever they like within that. But yeah, that's where I landed, where I am right now. So speaker-1: What an amazing journey and and it's so inspiring that you did this, that you didn't just have the idea, but you actually built it and created it and are now running these studies. yeah. It's amazing. And so you mentioned the the current study that you're doing, which is a kind of more I guess more broad DMA plus couple therapy study, which I think is quite maybe one of the first of its kind, because if I understand it correctly, you have to have a clinical indication to do psychedelic research. So you can do MDMA therapy with a couple where one member has PTSD, but with couple therapy that's more broad and more general, harder to get those studies funded. So this is really I mean, it's all very, very interesting, I guess, for for the many, many people who are engaging with relationship difficulties that may not have a psychiatric diagnosis and may not ever be in a psychedelic clinical trial, but maybe one day, maybe they have a couple therapy at the moment and maybe one day they're like, there may well be a time when my couple therapist can give us a few MDMA sessions. So given that I think it's fair to say that this is probably coming, would you agree with that? That there's probably gonna be a time when couple therapy can be speaker-0: Yeah. speaker-1: augmented or supplemented with some MDMA couples therapy sessions. This is something with huge reach and it potentially an incredibly wide-scale impact on our societies and our homes and our happiness. So yeah, tell us a bit about it. How can MDMA help couple therapy? And for people that may not have ever experienced MDMA or don't know anything about MDMA, Can you tell us what is an MDMA therapy session like and how might it be different to if people have ha experience of MDMA in a party context? How is it different when you do it as part therapy? speaker-0: I would say it's really different than when you someone would take it in a party or even on your own at home if you were if people are experimenting with their partners or friends. The context of doing it in therapy is is really quite unique, right? So you've got the idea that you're you're going in together, you're making the agreement that you're doing this together. And we embed it And we I think this is really important within psychotherapy. So it's not just about the MDMA session. It's about the work that you're doing ahead of time and the work that you're doing afterwards as well. Because otherwise, you could just go into the session and you might experience some shift or change, but what are you going to do with that? And right. And which obviously very well in your work with integration. And so yeah, what the things that we like to emphasize and we find really important initially are Around shared skills, around how do you talk about difficult things, how do you work with conflict so that people are feeling comfortable and on page with each other beforehand? And we're talking about intentions. And so we have folks talking about their individual intentions as well as their intentions as a couple. So what is it that they're wanting to focus on or look at or explore? And we're really careful to have people frame it as intentions and curiosities as opposed to goals. which, you know, we're in very goal oriented time of existing, which doesn't serve itself super well to an MDMA session. I say that with a laugh because it's I can never predict particularly how it's gonna go in these sessions. And there's a bit of a magic in that of going like, I don't know, I have to be very open minded and very curious in those moments. So Setting people up with those understandings and also setting them up that this could be challenging is, I think, very, very important. And MDMA is known as being this more quote unquote like gentle molecule than, for example, some other psychedelics, but it will allow you to be with things that are challenging and difficult. And so we also try to set people up to embrace that and encourage that. And this is an opportunity for them to Be with that together, but also with therapists in the room. So the model that we are using has two therapists present, which means that there's always an opportunity for one-on-one. If someone needs or wants to talk to one person, there's no one's left without someone to connect with. But there's, there's lots of support that's in the room with them. And When we're so the way we actually set it up in the room, our particular therapy room, we use futons that are made up like beds. And we have people's heads close together and their feet kind of out in a V. And then we have we have a sound system that's at their heads. So they're using headphones that's attached to that. And we also play the music in the room. And it's if anyone's ever seen photos of psychedelic sessions or videos, it looks like every other psychedelic session every other every other kind of modern trial psychedelic session where people are invited to use eye shades and to lay back and listen to the music on the headphones. And then what we do, and we're kind of honing and refining this, is helping folks navigate between their time inwards and their time connecting together. And that's interesting in terms of particularly following the lead of the the especially the person who wants to be inwards the most. there's often one person who is very drawn to their inner experience and we don't want to pull them away from that because there's usually something that's meaningful and important. and offering those opportunities to connect in. And so for us right now, like our context is still to get into the trial, someone has PTSD in the dyad. By the time, for example, they're in the crossover, that person may not have PTSD anymore. They may have actually received relief from the therapy. And so at that stage, they can be addressing whatever they want to be addressing in that session. They can be exploring whatever they want to explore. Usually there is still some trauma content that's coming out, but the partner is also has an opportunity to let go. Right. And so often these folks are caring deeply about their partners, have been kind of holding steady in the relationship and they get a chance to go, huh? And so the beauty of seeing these partners relax in, get to look at their own emotions. And I I've had several of them say, okay, great, you've got them. Amazing. I'm I'm gonna go inwards now for a bit. You're like, yeah. And then inviting them. And especially we, you know, we're getting into a rhythm of at the four-ish hour mark, if there isn't already a natural flow of going into conversation will start to invite that a bit more so that at that point people are past the peak and so they're a little bit more able to be verbal if they hadn't been before. And so just inviting them in these moments to connect in and share whatever's present or if there's anything that they want to be expressing about their experience. And it's that's really beautiful to witness. And some people will get in this rhythm If they'll go in for a spell, come out, share, go in, connect, share. and we have them close enough together where they can hold hands if they desire at any point in the journey. And that's really lovely too. And then also helping them be able to say to each other, Hey, I'd like my hand back. I'm just gonna go inwards to on my own for a little bit. So it's really it's nice to getting people to practice being being brave in their relationships and saying what they need and and not kind of being too careful around it with each other. So that's what in a nutshell kind of what it looks like. speaker-1: thank you so much. And that's so interesting actually because I had never quite realized that in MDMA therapy of the couples, or at least in this model that you're doing, it's not just about working on the couple relationship and talking it through and processing. It's also about each person having their own experience. So you're going through something together. You're there together going through a bonding experience, I suppose, as well. It's not just about going over the same things that you've been going over for years but just doing it with MDMA. It's actually very different. Very different model. speaker-0: It is. Yeah. And that's something that we've purposely designed because we think there's a lot of power in in the going internal and that's where a lot of the the gold comes from. And so to have the opportunity to go in and explore that and then come out and share that and work together on the things that are sticky can be really helpful, especially if you've cued them to their intention beforehand. Also, we're using a full dose of DMA, so we use a hundred milligrams in our study. And so, it's People have the ability to really explore inwards with them. But of course, this is one model of doing it. And it's interesting because we get a lot of like, this is like the first trial of this. And like, well, I mean, yeah, in this this particular model of doing research that we have in the, you know, twenty-first century, but it's not by any stretch the first time people are doing couples therapy with FDMA. There's been a long and rich history of people. doing it in under in the underground, people doing it on their own. so like this is one way and we're that we're experimenting and and learning from. speaker-1: Mm. And you mentioned the playlist. What kind of music do you play in a session? Because I imagine it's with a psilocybin playlist it's quite like present music. But maybe with this it's l a bit less I don't know, loud and part of the with the psilocybin playlist, it felt like almost like the the the the music was doing the kind of therapeutic work. Is it the same here or is the music more of a background? speaker-0: No, we we lean into the same kind of principles as for psilocybin assisted therapy. so it may be I'm trying think of the difference would be it's it's it still has that kind of cinematic arc and we do that on purpose of we you know the kind of the more gentle stuff at the beginning opening and the more anthemic stuff in the middle and then helping them land at the end and integrate. So yeah, we u currently use the same playlists across the study to keep it uniform. but the principle behind it is to have an arc of the experience and to also help people feel into things and and have it move it along. And we just had someone refer to the playlist with Whoa, that really got it going, right? It really helped the emotion move through. And so yeah, we use that as a tool. speaker-1: And what kind of things are you seeing? Like from all of your experience of all of these different MDMA, whether it's conjoint with C B C T, like all of the different MDMA sort of couples, whether there's one person with PTSD or whether, you know, however you've done it, what are you learning? What's what's your overall conclusions? But I'm sorry, I'm gonna say that differently. From all the studies you've now done with MDMA and couples, what would you say your overall conclusions? main reflections are. speaker-0: I would say that I am reaffirmed through it that bringing a loved one alongside you in the process is incredibly powerful. And it is interestingly, also, we're not just using romantic couples in the study right now. It's that we have other like family relationships and close friends as well. So Especially when I think of trauma and I think of and also I think of it in in a broad way. yes, we're studying PTSD, but so many of us, like 95% of us, will experience something traumatic in our lives. And to feel like we are not alone as we are navigating that and moving through the experience of healing from it, is incredibly powerful. And I think because it's such a hallmark of experiencing trauma to feel alone. And particularly if it was something that was interpersonal in nature. And I think that that's which is a lot of people's experiences and a lot of people who experienced childhood experiences that were not were not good. so to have someone else there with you and someone else you care about and you trust enough to go through the therapy. And of course I know that's not all people. Not everyone will have someone in their lives who is able or willing to do that with them. But if that is present, that it's it is such a resource and it is so useful, like even if the trauma symptoms don't move a ton, or even if there's still struggle in the relationship, to have the experience of doing that together is it really is impactful. And I think that that uniformly people would would offer that up. That that's that was a really important thing for them. I also see just the the ability for people to and this is across MDMA trials, like for individuals and for couples, just the ability to see change in ways that are not just the things that we're trying to measure as your outcomes. That is, you know, if I was just looking at moving PTSD symptoms or improving relationship satisfaction. the effort, the time, the energy, the expense of doing a psychedelic intervention, it may not feel quote unquote worth it, right? Because it's like sometimes those changes are equivalent to something you would see in another intervention. but the rest of the change, like that to me is the the biggest thing. People feel fundamentally different after going through this, even if They're still symptom and so and fundamentally different meaning it's opened something up. They've experienced something in a different way. And that to me is that is real healing and real growth around it, even if there's still places where they're struggling or there's still some symptoms that are there. There can be a lot broader of a shift, and that feels very generative. speaker-1: Hmm. Are there cobbles that you've worked with where in some way the MDMA experience made things worse or somebody had a kind of adverse reaction to it that was, you know, I think probably people that will be listening, maybe some people will be thinking, you know, how how safe is that to do? how safe is it for everybody? Is it, you know, just some people have really difficult experiences? Have you found any of those adverse events? speaker-0: Yeah, I think there of course we have adverse events in terms of people having side effects and whatnot. The vast majority of the the adverse events that we've seen in all of our studies have resolved. and so they're not things that continue on. And typically our the ones that we see are often physiological. and there's sometimes maybe I think particularly between our MDMA sessions, 'cause we have two in our studies. there can be a lot of emotional rawness that emerges. And we're holding that therapeutically for people. So you may see in an exacerbation of symptoms at that point in time, but in service of them getting examined and worked through and then it's held in the container. I think it's incredibly important the strength of the therapeutic container around it. And I'm actually a big fan of using these more structured therapies around it because it offers folks a real sense of safety and security. I think there's many ways you could operate, but I know there's a there's a comfort in having the the stability around it. I would say relationally, we do see it shake up relational patterns. you know, I think generally it's a good thing, but I think it can feel uncomfortable at different times and people will notice that. I haven't seen, you know, I'm gonna caveat this with going like no, I don't I actually don't think I've seen any relational worsening in the studies. granted we haven't seen hundreds and hundreds of dyads, we've seen a smaller number than that. But I have I haven't seen worsening. And I and I in terms of people's PTSD symptoms There have been sometimes we'll see fluctuations in them over time. And so, there are some that would say there is there would be improvement and maybe the improvement isn't maintained over time, or that there is people are still symptomatic at the end. But yeah, I would say that the majority of the adverse events are things that would result. And that it may shake it up. And then we're always careful that if people do need additional support after the trials, we're very careful to connect them with good psychotherapeutic care afterwards. And some people want to continue, and it's it's not a negative thing continuing with therapy. They're just like, yeah, I've I'm on this good path now and I want to continue. Some people are like, I still have some symptoms. I'd like to keep continuing working on them. So yeah, I would say that yeah, it's definitely not. all roses and and kittens, it it's it's there can be a lot of hard work and challenge and difficult emotion comes with it, but there there haven't been these really kind of explosive outcomes that or really really, really negative ones. But we're very careful therapeutically to ensure the container is really solid for folks. speaker-1: And how far away are we from this being something that people can access? I mean, obviously that's different in different parts of the world, but how yeah, like what's the roadmap from where we are to people being able to access MDMA therapy for couples? speaker-0: Yeah, it's a great question. I think the way I see it will likely happen is once MDMA is approved for an indication, which is likely to gonna be PTSD and hopefully within the not too distant future, then at that point when it's prescribable as a medicine. There's a high likelihood that people will start to prescribe it, quote unquote, off-label for different things, which is what we see with all kinds of therapeutic therapeutics in general. And at that point, from what my understanding is, is that if people have if there's data to support the use for an off-label indication. So for example, the data we're collecting use doing clinical trials. and showing that it's safe and efficacious, that that could be something that could be prescribed off label. And so that is my hope, is that that my understanding is correct, first of all. Please someone correct me if I'm not correct. that that would be the case. So I would imagine it wouldn't be in the too distant future once MDMA is able to be prescribed for something. And that means we need to continue to do our research to have the data to support that use so that the prescribers are able to go, look, this this it was used in these clinical trials and this is the safety profile and this is the impact that it has. So that's that's what we're kind of aiming towards. speaker-1: Mm-hmm. And Anna at some point are you gonna write a book about this? I so. speaker-0: Yes. Well yes. The the when is a good question. I think I need to finish the trial first, but it will it will happen at at some point. Yeah. speaker-1: And you are you're quite a prolific publisher anyway. So of all of the the different things you've written, is there something you could suggest that you've written or something that somebody else has written that people that are really interested in this could read to find out a little bit more about this work? Where's a good place to start? speaker-0: Yeah, so there are a number of different places. I would say if you're interested in the historical pieces, reading things that Anne Shulgin has written is really beautiful because she I would I would credit her again, people can correct me if I'm wrong in this one, is I would say she's probably the first person who ever did couples therapy with DMA. Anne Shulgin was I guess one we could call her a lay therapist, so she wasn't she didn't have a professional designation, but she Offery as the therapist. And Anne was the wife of Sasha Shulgan, who is a chemist, who's considered kind of the godfather of MDMA, meaning he resynthesized MDMA and was able to offer it and distribute it to colleagues who used it in psychotherapy. And so she got it, was had synthesized by Sasha and would use it. And this was also, of course, before it became illegal. So this would have been in the in the seventies and early eighties. And so they just had a an incredible trove of information about that. And there's a great documentary about them called Better Living Through Chemistry. I recommend it. So yeah, I just I think understanding your history is really, really important in this. So huge credit to speaker-1: And actually their Shulgin farm is such an amazing place to go because you can see his his cabin where he discovered all these different formulas and compounds and just spent his whole time, it looks like, with test tubes and figuring out these different compounds and a huge load of filing cabinets with all the different things he was discovering. And then she had this amazing huge table overlooking this valley and all these trees where you can just imagine the therapy groups. I think they had like kind of women's therapy. circle too. So yeah, very inspired. I love the fact that this is where it all emerged from. speaker-0: Yeah, absolutely. You can see, you can feel like on that land and with the the trees and the valley, you can imagine the experiences that people were having there and having seeing it in the clinic room and then getting to see where it originated. You're like, that's amazing. Yeah. So highly recommend starting there. And then if you enjoy science around this, then we have some some papers we've published on this. some of them are open access and so you can look them up on Google Scholar. If you look up you just Google my name and MDMA, they're available. So there that would be another way to do some learning if people are interested. speaker-1: Thank you, Ann. How would you say, as a result of this work that you've been doing, how how are you different? Like it's as you say, you've been doing this for twelve years working in the psychedelic world. And we've had many conversations over the years about the good things and the not so good things about the psychedelic world, psychedelic industry, but it's a deep, profound journey in a way, working in this field, not just working with people going through these experiences, but being part of this whole field at this particular time. How do you feel now, twelve years on from when you first started, how would you say that you've been impacted? How are you different as a person now than you were then? speaker-0: I'm hugely impacted. I would say the first thing that came to mind, which is interesting, is like I'm a lot less naive than I once was. I mean, granted, was a lot younger than too, but it's just understanding that there's so many different forces at play and having learned to be as someone who's not particularly patient by nature, having learned how to be a lot more patient and understand that if I really believe in something, which I do about this, I really do, and the the amount of effort and time and energy, blood, sweat and tears this has taken, that you know, there's many, many parts within me that go, just run away and go do something else. Like it is too hard. And then understanding that like, no, there's it just lean into It's gonna take the time it takes. It's gonna be slow and it's gonna keep moving, and you're just going to need to be with that. And that's one of the biggest lessons I've learned. Is also the other thing I've learned is and I feel quite proud of is I won't back down from my own ethical and moral stance around things. And that the choice to do that and the values I hold, meaning that really valuing the therapy, really valuing doing this in right relationship with everyone that I can and and following that has meant that we've continued. you know, there's been a lot of things that have come and gone, I would say, through this. And there was times where that brought lots of fear when there was lots of different energy coming into this field and then anger. And then now it's like, okay. No, we just continued on. And that feels like its own, I guess, testimony to how we can do this work in a way that is, it may not produce the most results the fastest, or it may not, it certainly won't make us the most money, that is for sure. But to me that's not the point. The point is to try to help folks access the treatment, the healing, the growth that's possible for them and to help reduce suffering. So I think it's been in some ways an affirmation of the things I hoped for, and then other ways an extremely big challenge along the way that has shaped me and forged me in different ways. And it's a constant conversation with myself around how do I continue to do this in a way that feels sustainable over time. And that means for me going slower than I think a lot of people maybe have the patience for. And sometimes I don't have the patience for either. But so that's my own inner work. speaker-1: It's such an important thing for us to hear about because psychedelic models, as they are mainstreaming, coming to this place of it is essential to strip up most of the therapeutic elements. People are talking about psychological support rather than psychedelic therapy. In the mainstream models, there is less and less therapeutic support and social support. And we're almost getting to the point of people just acknowledging that that's just the way it has to be because this is Medical companies doing this, this is pharma companies that are gonna be doing this, and it's trying to fit a circle into a square hole. And so we have to chop the edges off the circle so that it fits that square shaped hole, so that it can fit into these kind of models. But what you've been able to do is say, No, I'm gonna keep the circle a circle and I'm gonna offer this model my way in the way that we feel is ethical and good and slow. And you'll prove that actually psychedelic therapy can be given. in a way that works well for your clients and is more sustainable for the staff members and people are accessing the kind of care they need. So could we, if more people wanted to set up clinics, could we potentially have a whole network of clinics that were licensed to do these research studies and offer therapies alongside? Could we have that? speaker-0: I think so. I think what's one thing that might be different about how we do this work here is that I'm a psychologist as opposed to a different discipline. And so when I think about how we do this work, it's actually psychotherapy first and medicine is an adjunct to that. So it's they're not actually I I don't label them as being psychedelic trials. They're psychotherapy trials that happen to also have psychedelic involved, which is not how the vast majority of the studies run or the the theory behind them. So I think that's an essential difference behind them. I think also I I would hope that there could and actually one of the the hopes with Remedy is that people will take this model and replicate it, right? And we think about Bennett Zellner's idea of of pollinator models. that the whole concept of this is please, please take this model and do it somewhere else too. And just be ready for it to take a while. It's not something that's gonna be a quick moneymaker about as not happening. And I think a lot of people when they think about doing something like that, they or kind of having the the drive to build something. they may have other attributes within them that want fast or want the fruits of their labor to show faster and that may not be feasible. So if you can cultivate patience and if you have the wherewithal to build something that a hundred percent and I would love and that that would be amazing if we could have more and more demonstration of that. And then I think the other thing that we're at the edge of trying to figure out is how to make sure we're accessing For example, grant funding. So we've designed ourselves to be meeting all the criteria, for example, for our our national government funding for things, but we haven't yet accessed it. Actually, some of my grad students have. They've gotten been successful. But as a clinic or as Remedy Institute, that would be for me something that would be the next step to try to do. And then we'll see if the systems the granting agency systems feel good with that because right now it's all philanthropically funded. So that we are also kind of navigating the waves of people's generosity or what they're wanting to put their money behind, as all nonprofits and charities do. But the idea is that we also are designing this so that when we're able to do, for example, MDMA assisted therapy in the clinic when it's approved, We have the charity that can run research and therefore we're able to do program outcome research. And so that is partly built into it. And that is a sustainable model that we wouldn't need external funding for. And so that's the long term vision of it and that we're planning. And in fact, we're we haven't been offering ketamine assisted therapy up until now. And we're about to start offering it because we feel like we can do it now in a way that matches how we do our MDMA assisted work. And so we'll be able to practice that and do our program evaluation research on that and have that all ready for when MDMA or psilocybin are able to be offered. speaker-1: And is the ketchup in work is with individuals rather than with couples? speaker-0: So our intentions is do individuals and couples. Yeah. That'll be in the new year in twenty twenty seven. speaker-1: Wow, we'll have to have you back on the podcast to talk about that when that's happening. and you're doing such amazing work. And yeah, I love the idea that you're providing this blueprint for the people to be able to set up these kind of clinics in other places. And I really deepest wish to see lots of them popping up because those people that are lucky enough to live in the Toronto area, they can come to Remedy. But for everyone else that's listening, it's a very long way for us to come. speaker-0: Better. speaker-1: But Doctor Anne Wagner, it's been a real pleasure. Thank you for talking to us. speaker-0: thank you so much, Roz. I'm so glad to be here with you. speaker-1: and thank you everyone for listening to this episode of Stand in a Circle and we will see you next time.